<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background: The association between <z:hpo ids='HP_0000704'>periodontitis</z:hpo> and <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic diseases</z:e> including <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> and <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> has repeatedly been recognized </plain></SENT>
<SENT sid="1" pm="."><plain>Paraoxonase-1 is involved in the prevention of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and decreased enzyme activity in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> has been shown </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to investigate a possible correlation between decreased Paraoxonase-1 activity and the association between impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism or <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000704'>periodontitis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Methods: Paraoxonase-1 phenotype distribution and enzyme activities were characterized by measuring the hydrolysis of <z:chebi fb="0" ids="8082">phenylacetate</z:chebi> and <z:chebi fb="0" ids="27827">paraoxon</z:chebi> in serum samples of 87 type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients and 46 prediabetes patients showing impaired fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and/or impaired oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="4" pm="."><plain>The control group comprised 64 subjects (<z:mpath ids='MPATH_458'>normal</z:mpath> fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance) </plain></SENT>
<SENT sid="5" pm="."><plain>Altogether 154 study subjects were available for complete clinical periodontal examination </plain></SENT>
<SENT sid="6" pm="."><plain>Results: No difference in <z:hpo ids='HP_0000704'>periodontitis</z:hpo> prevalence existed between the study groups </plain></SENT>
<SENT sid="7" pm="."><plain>However, <z:mp ids='MP_0002055'>diabetes</z:mp> patients had an increased risk of suffering from <z:hpo ids='HP_0011058'>generalized periodontitis</z:hpo> (adjusted odds ratio: 4.05; 95 % confidence interval: 1.24 to 13.18, p = 0.02) and their Paraoxonase-1 activity was reduced compared to controls </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> subjects did neither show an increased <z:hpo ids='HP_0000704'>periodontitis</z:hpo> risk nor an impaired paraoxonase status </plain></SENT>
<SENT sid="9" pm="."><plain>Paraoxonase-1 was not associated directly with <z:hpo ids='HP_0000704'>periodontitis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Nevertheless, concerning <z:mp ids='MP_0002055'>diabetes</z:mp> patients, poor oral hygiene, male gender, and Paraoxonase-1 phenotype were found to be significant predictors for <z:hpo ids='HP_0000704'>periodontitis</z:hpo> extent </plain></SENT>
<SENT sid="11" pm="."><plain>Conclusion: <z:mp ids='MP_0002055'>Diabetes</z:mp> type 2 but not a prediabetec state increases the risk of <z:hpo ids='HP_0011058'>generalized periodontitis</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Paraoxonase-1 status in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients may contribute to this association </plain></SENT>
</text></document>